The MSH2- and MLH1-associated lifetime risk for developing colorectal cancer, and MSH2- and MSH6-associated risk for developing endometrial cancer has been estimated to be over 10-fold, compared with the general population (4, 6). Here, MSH6 is linked to endometrial cancer.